(Q35885293)

English

Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study

scientific article published on 24 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study (English)

1 reference

Europe PubMed Central

10 August 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Richard C Harvey

object named as

Richard C Harvey

2

0 references

Sarah K. Tasian

object named as

Sarah K Tasian

13

0 references

Charles G. Mullighan

object named as

Charles G Mullighan

3

0 references

Stephen P Hunger

21

object named as

Stephen P Hunger

1 reference

Europe PubMed Central

10 August 2017

Cheryl L. Willman

22

object named as

Cheryl L Willman

1 reference

Europe PubMed Central

10 August 2017

Julie Gastier-Foster

4

object named as

Julie Gastier-Foster

1 reference

Europe PubMed Central

10 August 2017

Meenakshi Devidas

10

object named as

Meenakshi Devidas

1 reference

Europe PubMed Central

10 August 2017

19

object named as

Mignon L Loh

1 reference

Europe PubMed Central

10 August 2017

20

object named as

Naomi J Winick

1 reference

Europe PubMed Central

10 August 2017

Shalini C Reshmi

14

object named as

Shalini Reshmi

1 reference

Europe PubMed Central

10 August 2017

Bruce M Camitta

8

object named as

Bruce M Camitta

1 reference

Europe PubMed Central

10 August 2017

Michael J Borowitz

7

object named as

Michael J Borowitz

1 reference

Europe PubMed Central

10 August 2017

17

object named as

W Paul Bowman

1 reference

Europe PubMed Central

10 August 2017

16

object named as

Gregory H Reaman

1 reference

Europe PubMed Central

10 August 2017

6

object named as

Huining Kang

1 reference

Europe PubMed Central

10 August 2017

5

object named as

Walker Wharton

1 reference

Europe PubMed Central

10 August 2017

D Jeanette Pullen

11

object named as

D Jeanette Pullen

1 reference

Europe PubMed Central

10 August 2017

Debbie Payne-Turner

12

object named as

Debbie Payne-Turner

1 reference

Europe PubMed Central

10 August 2017

author name string

I-Ming Chen

1

1 reference

Europe PubMed Central

10 August 2017

Andrew J Carroll

9

1 reference

Europe PubMed Central

10 August 2017

Catherine E Cottrell

15

1 reference

Europe PubMed Central

10 August 2017

William L Carroll

18

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

24 February 2012

1 reference

Europe PubMed Central

10 August 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

10 August 2017

119

1 reference

Europe PubMed Central

10 August 2017

15

1 reference

Europe PubMed Central

10 August 2017

3512-3522

1 reference

Europe PubMed Central

10 August 2017

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

JAK mutations in high-risk childhood acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

SNPdetector: a software tool for sensitive and accurate SNP detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Post-PCR multiplex fluorescent ligation detection assay and flow cytometry for rapid detection of gene-specific translocations in leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

11 July 2018

Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

24 September 2018

Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325039

24 September 2018

Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/22368272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22368272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2011-11-394221

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35885293&oldid=1901871454"